Explore Products

My Quote Request

No products added yet

6505-01-165-1482

20 Products

ZANTAC TABLETS

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

View More Info

ZANTAC TABLETS

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS

NDC50111-0391-02

SALSALATE TABLETS,USP

NSN, MFG P/N

6505011646861

NSN

6505-01-164-6861

View More Info

NDC50111-0391-02

SALSALATE TABLETS,USP

NSN, MFG P/N

6505011646861

NSN

6505-01-164-6861

MFG

SIDMAK LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS SALSALATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALSALATE TABLETS 750MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00067-0300-68

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

NDC00067-0300-68

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

NDC00075-0300-00

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

NDC00075-0300-00

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

NDC00258-3625-01

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

NDC00258-3625-01

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

INWOOD LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

NDC00603-5952-21

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

NDC00603-5952-21

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

NDC00904-7849-60

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

NDC00904-7849-60

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

MAJOR PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

SLO-BID

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

SLO-BID

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

SLO-BID GYROCAPS

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

View More Info

SLO-BID GYROCAPS

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648736

NSN

6505-01-164-8736

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

NDC00075-0300-62

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

NDC00075-0300-62

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

NDC00258-3625-01

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

NDC00258-3625-01

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

INWOOD LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

NDC00603-5952-21

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

NDC00603-5952-21

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

NDC00904-7849-60

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

NDC00904-7849-60

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

MAJOR PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

SLO-BID 300

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

SLO-BID 300

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

SLO-BID 300 GYROCAPS

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

View More Info

SLO-BID 300 GYROCAPS

THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP

NSN, MFG P/N

6505011648737

NSN

6505-01-164-8737

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM

2B0852

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

View More Info

2B0852

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24

GENTAMICIN VIAFLEX

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

View More Info

GENTAMICIN VIAFLEX

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24

NDC00264-5816-38

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

View More Info

NDC00264-5816-38

GENTAMICIN SULFATE INJECTION,USP

NSN, MFG P/N

6505011648859

NSN

6505-01-164-8859

MFG

B BRAUN MEDICAL INC WOUND CARE DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24

NDC00173-0344-47

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

View More Info

NDC00173-0344-47

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS

ZANTAC

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

View More Info

ZANTAC

RANITIDINE TABLETS,USP

NSN, MFG P/N

6505011651482

NSN

6505-01-165-1482

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS